American Portfolios Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

American Portfolios Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3.19K	Hold	638	–	–	﹤0.01%	2979
2022 Q2	$3.72K	Hold	638	–	–	﹤0.01%	2946
2022 Q1	$4.54K	Hold	638	–	–	﹤0.01%	2977
2021 Q4	$8.41K	Sell	638 -230	-26%	-$3.8K	﹤0.01%	2694
2021 Q3	$20K	Sell	868 -50	-5%	-$1.49K	﹤0.01%	2289
2021 Q2	$40.3K	Buy	918 +50	+6%	+$2.79K	﹤0.01%	1843
2021 Q1	$63K	Buy	868 +365	+73%	+$25.9K	﹤0.01%	1510
2020 Q4	$21.7K	Sell	503 -100	-17%	-$4.48K	﹤0.01%	1776
2020 Q3	$24.8K	Buy	603 +400	+197%	+$20.7K	﹤0.01%	1607
2020 Q2	$12.2K	Buy	203 +90	+80%	+$8.24K	﹤0.01%	1850
2020 Q1	$8.47K	Hold	113	–	–	﹤0.01%	1882
2019 Q4	$15.5K	Buy	113 +25	+28%	+$3.04K	﹤0.01%	1834
2019 Q3	$10.4K	Hold	88	–	–	﹤0.01%	1919
2019 Q2	$12.2K	Buy	+88	New	+$15.5K	﹤0.01%	1840

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

American Portfolios Advisors's ORTX Position: Q3 2022 in Review

American Portfolios Advisors held its Orchard Therapeutics plc American Depositary Shares (ORTX) position steady in Q3 2022 at 638 shares worth $3.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

American Portfolios Advisors first reported a position in ORTX in Q2 2019 and has held it in 14 quarters since. The position peaked at $63K in Q1 2021. 47 funds tracked by Wall St. Rank hold ORTX as of Q3 2022.

American Portfolios Advisors held 638 shares of Orchard Therapeutics plc American Depositary Shares worth $3.19K as of Q3 2022.
American Portfolios Advisors left its Orchard Therapeutics plc American Depositary Shares share count unchanged in Q3 2022.
Orchard Therapeutics plc American Depositary Shares made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2979 holding.
American Portfolios Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and has held it in 14 quarters since.
American Portfolios Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $63K in Q1 2021.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.